Cargando…
Impact of model misspecification on model-based tests in PK studies with parallel design: real case and simulation studies
This article evaluates the performance of pharmacokinetic (PK) equivalence testing between two formulations of a drug through the Two-One Sided Tests (TOST) by a model-based approach (MB-TOST), as an alternative to the classical non-compartmental approach (NCA-TOST), for a sparse design with a few t...
Autores principales: | Guhl, Mélanie, Mercier, François, Hofmann, Carsten, Sharan, Satish, Donnelly, Mark, Feng, Kairui, Sun, Wanjie, Sun, Guoying, Grosser, Stella, Zhao, Liang, Fang, Lanyan, Mentré, France, Comets, Emmanuelle, Bertrand, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483500/ https://www.ncbi.nlm.nih.gov/pubmed/36112338 http://dx.doi.org/10.1007/s10928-022-09821-z |
Ejemplares similares
-
Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies
por: Tardivon, Coralie, et al.
Publicado: (2023) -
On the consequences of model misspecification in logistic regression.
por: Begg, M D, et al.
Publicado: (1990) -
Misspecification of Cox regression models with composite endpoints
por: Wu, Longyang, et al.
Publicado: (2012) -
Genetic model misspecification in genetic association studies
por: Gaye, Amadou, et al.
Publicado: (2017) -
Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation
por: Baklouti, Sarah, et al.
Publicado: (2023)